Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Vaxart Inc VXRT

Healthcare Biotechnology
Vaxart, Inc. is a clinical-stage biotechnology company that is primarily focused on the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) proprietary oral vaccine platform. Its vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Its... see more

Recent & Breaking News (NDAQ:VXRT)

Vaxart Provides Business Update and Reports First Quarter 2022 Financial Results

GlobeNewswire May 9, 2022

Vaxart to Present at World Vaccine Congress Washington 2022 on April 20

GlobeNewswire April 14, 2022

Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results

GlobeNewswire February 24, 2022

Vaxart's S-Only COVID-19 Vaccine Candidate Produces Strong-Cross Reactive Mucosal and Systemic Immune Responses in Non-Human Primates

GlobeNewswire February 24, 2022

Vaxart Appoints Edward Berg as Senior Vice President and General Counsel

GlobeNewswire February 14, 2022

Vaxart to Participate at the H.C. Wainwright BioConnect Virtual Conference

GlobeNewswire January 4, 2022

Vaxart to Test Cross-Reactivity of its COVID-19 Oral Tablet Vaccine Against Omicron

GlobeNewswire December 16, 2021

Vaxart Announces Acquisition of Second GMP Manufacturing Facility

GlobeNewswire December 1, 2021

Vaxart to Present at World Vaccine & Immunotherapy Congress West Coast 2021 on November 30, 2021 

GlobeNewswire November 23, 2021

Stanford Scientists First To Identify New Cellular Correlates of Protection Against Influenza for an Oral Flu Vaccine Developed by Vaxart

GlobeNewswire November 18, 2021

Vaxart Announces Publication of Complete Data from Preclinical COVID-19 Oral Vaccine Hamster Challenge Study in Journal of Infectious Diseases

GlobeNewswire November 16, 2021

Vaxart to Participate at Upcoming Conferences

GlobeNewswire November 11, 2021

Vaxart Provides Business Update and Reports Third Quarter 2021 Financial Results

GlobeNewswire November 4, 2021

Vaxart Doses First Subject in Phase II COVID-19 Oral Tablet Vaccine Clinical Trial

PR Newswire October 26, 2021

New Duke University-led Study Shows That Vaxart's Oral COVID-19 Vaccine Candidate Reduces Airborne Transmission of SARS-CoV-2 Infection in Animal Model

PR Newswire October 7, 2021

Vaxart Begins Recruiting in Global Phase II COVID-19 Oral Tablet Vaccine Clinical Trial

PR Newswire October 6, 2021

Did You Acquire (VXRT) Before June 25, 2020? Johnson Fistel Investigates Vaxart; Should Management be Held Accountable for Investors Losses?

PR Newswire October 2, 2021

Vaxart Appoints Dr. James F. Cummings as Chief Medical Officer

PR Newswire September 27, 2021

Vaxart To Present at Upcoming Vaccine Conferences

PR Newswire September 22, 2021

Vaxart Announces Creation of Manufacturing and Quality Advisory Board

PR Newswire September 21, 2021